Research Institute of Molecular Pathology (IMP)
Johannes Zuber is currently working as a Senior Group Leader at the Research Institute of Molecular Pathology (IMP) since January 2011. Prior to this, Johannes was a Postdoc/Clinical Research Fellow at Cold Spring Harbor Laboratory from August 2005 to December 2010. Johannes is also a Co-Founder & Scientific Advisor at QUANTRO Therapeutics GmbH since July 2020. In addition, Johannes holds the title of Adjunct Professor at the Medical University of Vienna since 2017. Johannes Zuber previously worked as a Resident Doctor in Hematology/Oncology at Charité from August 2001 to July 2005. Johannes obtained their Doctor of Medicine (MD) degree in Medicine from Humboldt-Universität zu Berlin in 2000.
This person is not in any teams
Research Institute of Molecular Pathology (IMP)
The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by Boehringer Ingelheim. With over 200 scientists from 40 countries, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms underlying complex biological phenomena. Research areas include cell and molecular biology, microscopy, immunology and cancer, developmental biology, chromosome biology, and computational biology.